Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious?

被引:1151
作者
Virmani, R
Guagliumi, G
Farb, A
Musumeci, G
Grieco, N
Motta, T
Mihalcsik, L
Tespili, M
Valsecchi, O
Kolodgie, FD
机构
[1] Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Washington, DC 20306 USA
[2] Osped Riuniti Bergamo, Cardiovasc Dept, I-24100 Bergamo, Italy
[3] Osped Riuniti Bergamo, Dept Pathol, I-24100 Bergamo, Italy
关键词
sirolimus; stents; thrombosis; death; sudden;
D O I
10.1161/01.CIR.0000116202.41966.D4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The US Food and Drug Administration recently issued a warning of subacute thrombosis and hypersensitivity reactions to sirolimus-eluting stents ( Cypher). The cause and incidence of these events have not been determined. Methods and Results - We present findings of a 58-year-old man who died of late stent thrombosis 18 months after receiving 2 Cypher stents for unstable angina. Although angiographic and intravascular ultrasound results at 8 months demonstrated the absence of neointimal formation, vessel enlargement was present. An autopsy showed aneurysmal dilation of the stented arterial segments with a severe localized hypersensitivity reaction consisting predominantly of T lymphocytes and eosinophils. Conclusions - The known pharmacokinetic elution profile of Cypher stents and the presence of polymer fragments surrounded by giant cells and eosinophils suggest that a reaction to the polymer may have caused late stent thrombosis. Careful long-term follow-up of patients with vessel enlargement after Cypher stent placement is recommended.
引用
收藏
页码:701 / 705
页数:5
相关论文
共 30 条
[1]   Occupational allergies caused by latex [J].
Ahmed, DDF ;
Sobczak, SC ;
Yunginger, JW .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2003, 23 (02) :205-+
[2]   Pilot trial of oral rapamycin for recalcitrant restenosis [J].
Brara, PS ;
Moussavian, M ;
Grise, MA ;
Reilly, JP ;
Fernandez, M ;
Schatz, RA ;
Teirstein, PS .
CIRCULATION, 2003, 107 (13) :1722-1724
[3]   Bicetre Hospital experience with sirolimus-based therapy in human renal transplantation:: The Sirolimus European Renal Transplant study [J].
Charpentier, B ;
Groth, CG ;
Bäckman, L ;
Morales, JM ;
Calne, R ;
Kreis, H ;
Lang, P ;
Touraine, JL ;
Claesson, K ;
Carnpistol, JM ;
Durand, D ;
Wrarnner, L ;
Brattström, C .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) :58S-61S
[4]   Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions - An intravascular ultrasound analysis [J].
Degertekin, M ;
Serruys, PW ;
Tanabe, K ;
Lee, CH ;
Sousa, JE ;
Colombo, A ;
Morice, MC ;
Ligthart, JMR ;
de Feyter, PJ .
CIRCULATION, 2003, 108 (22) :2747-2750
[5]   Pathological mechanisms of fatal late coronary stent thrombosis in humans [J].
Farb, A ;
Burke, AP ;
Kolodgie, FD ;
Virmani, R .
CIRCULATION, 2003, 108 (14) :1701-1706
[6]   Morphological predictors of restenosis after coronary stenting in humans [J].
Farb, A ;
Weber, DK ;
Kolodgie, FD ;
Burke, AP ;
Virmani, R .
CIRCULATION, 2002, 105 (25) :2974-2980
[7]   RAPAMYCIN INHIBITS AIRWAY LEUKOCYTE INFILTRATION AND HYPERREACTIVITY IN GUINEA-PIGS [J].
FRANCISCHI, JN ;
CONROY, D ;
MAGHNI, K ;
SIROIS, P .
AGENTS AND ACTIONS, 1993, 39 :C139-C141
[8]   Requirement for IL-13 independently of IL-4 in experimental asthma [J].
Grünig, G ;
Warnock, M ;
Wakil, AE ;
Venkayya, R ;
Brombacher, F ;
Rennick, DM ;
Sheppard, D ;
Mohrs, M ;
Donaldson, DD ;
Locksley, RM ;
Corry, DB .
SCIENCE, 1998, 282 (5397) :2261-2263
[9]   Sirolimus-induced leukocytoclastic vasculitis [J].
Hardinger, KL ;
Cornelius, LA ;
Trulock, EP ;
Brennan, DC .
TRANSPLANTATION, 2002, 74 (05) :739-740
[10]   Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent [J].
Klugherz, BD ;
Llanos, G ;
Lieuallen, W ;
Kopia, GA ;
Papandreou, G ;
Narayan, P ;
Sasseen, B ;
Adelman, SJ ;
Falotico, R ;
Wilensky, RL .
CORONARY ARTERY DISEASE, 2002, 13 (03) :183-188